# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-122529
Filing Date
2019-04-26
Accepted
2019-04-26 16:44:57
Documents
3
Period of Report
2019-06-18
Effectiveness Date
2019-04-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d655532ddef14a.htm | DEF 14A | 727879
2 | GRAPHIC | g655532img1.jpg | GRAPHIC | 408227
3 | GRAPHIC | g655532img2.jpg | GRAPHIC | 226624
| Complete submission text file | 0001193125-19-122529.txt |  | 1603789

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 19772320
SIC: 2834 Pharmaceutical Preparations